1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
Real-time Euronext Amsterdam  -  11:37 2022-06-29 am EDT
20.45 EUR   -0.07%
10:36aPhilips provides update on Philips Respironics PE-PUR sound abatement foam test and research program
AQ
08:45aPHILIPS NV : Jefferies reiterates its Neutral rating
MD
06:54aPHILIPS NV : Deutsche Bank sticks Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philips Annual General Meeting of Shareholders approves dividend and other proposals made to shareholders

05/10/2022 | 10:48am EDT


May 10, 2022

Philips’ Supervisory Board takes note of the advisory vote on the 2021 Remuneration Report, will continue to engage with shareholders and consider the feedback received in its next remuneration report

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced that today’s Annual General Meeting of Shareholders (2022 AGM) has approved the company’s proposed dividend of EUR 0.85 per share over 2021, and appointed Mrs. Herna Verhagen and Mr. Sanjay Poonen and re-appointed Dr. Paul Stoffels and Dr. Marc Harrison as members of the Supervisory Board.

All other binding voting items, such as the re-appointment of Ernst & Young Accountants LLP as the company’s auditor, and a number of recurring items, such as the proposal to adopt the company’s financial statements, were also approved.

“I am pleased to welcome Herna Verhagen and Sanjay Poonen as new members of the Supervisory Board, and Paul Stoffels and Marc Harrison as continued members,” said Feike Sijbesma, Chairman of the Supervisory Board of Royal Philips. “Their combined expertise and counsel are very valuable for Philips. I would also like to thank Neelam Dhawan, who has now retired from the Supervisory Board, for her long-term counsel and support since 2012.”

Mr. Sijbesma continued: “We have also taken note of the advisory vote on the 2021 Remuneration Report. We take the feedback seriously and will continue the constructive dialogue and consultation with our shareholders.”

Further details about the dividend can be found via this link, and additional information on the composition of the Board of Management, the Executive Committee and the Supervisory Board can be found here.

Philips’ 2021 financial statements are included in its 2021 Annual Report that was published on February 22, 2022.

For more information about Philips’ 2022 AGM, please click on this link.


For further information, please contact:

Ben Zwirs
Philips Global Press Office
Tel.: +31 615213446
E-mail: ben.zwirs@philips.com

Derya Guzel
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: derya.guzel@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.


All news about PHILIPS NV
10:36aPhilips provides update on Philips Respironics PE-PUR sound abatement foam test and res..
AQ
08:45aPHILIPS NV : Jefferies reiterates its Neutral rating
MD
06:54aPHILIPS NV : Deutsche Bank sticks Neutral
MD
06/28U.S. FDA classifies recall of GE's ventilator batteries as most serious
RE
06/28PHILIPS NV : JP Morgan maintains a Sell rating
MD
06/28PHILIPS NV : UBS remains a Sell rating
MD
06/28PHILIPS NV : Jefferies reiterates its Neutral rating
MD
06/28Philips says tests on recalled ventilators 'very encouraging'
RE
06/28Royal Philips' Unit Conducts Test on Devices Affected by Recall Notification
MT
06/28Philips' Recalled Ventilator Devices Show 'Very Low' Occurrence Of Visible Foam Degrada..
MT
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2022 18 194 M 19 050 M 19 050 M
Net income 2022 805 M 843 M 843 M
Net Debt 2022 4 282 M 4 484 M 4 484 M
P/E ratio 2022 21,2x
Yield 2022 4,37%
Capitalization 18 227 M 19 084 M 19 084 M
EV / Sales 2022 1,24x
EV / Sales 2023 1,15x
Nbr of Employees 78 189
Free-Float 98,4%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 20,45 €
Average target price 30,12 €
Spread / Average Target 47,3%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Shez Partovi Chief Medical, Innovation & Strategy Officer
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-37.54%19 199
THERMO FISHER SCIENTIFIC-18.52%209 734
DANAHER CORPORATION-23.44%180 320
INTUITIVE SURGICAL, INC.-43.78%72 506
EDWARDS LIFESCIENCES CORPORATION-26.88%58 899
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-18.07%57 134